Aa
Orlean's Post Regarding Stevioside/Curcumin Study
I AM REPOSTING ORLEAN'S ORIGINAL POST, AS WE ALL ENDED UP DISCUSSING SWEETENERS INSTEAD OF HOW TO USE STEVIA WHITH TX
LET'S NOT DISCUSS SWEETENERS PROS AND CONS ON THIS THREAD.
Marcia
Herbal Product Stevioside Inhibits HCV Replication and Curcumin Suppresses Fibrogenic Cell Activity in Laboratory Studies
Last updated:26June2008
Intro
Stevioside
Curcumin
By Liz Highleyman hivandhepatitis.com
Intro
Given the suboptimal response rate and difficult side effects associated with standard interferon-based therapy for chronic hepatitis C virus (HCV) infection, many patients have used various alternative and complementary therapies, and researchers have assessed several such agents in laboratory and clinical studies.
At the Digestive Disease Week 2008 conference last month in San Diego, researchers reported on 2 plant-derived therapies that may have the potential to inhibit HCV and improve liver fibrosis.
Top
Stevioside
In the first study, Kazuhisa Yuasa and colleagues assessed the in vitro anti-HCV activity of stevioside, an agent derived from the leaves of the Stevia rebaudiana plant that is used as a natural non-caloric sweetener.
Stevioside has been reported to have anti-inflammatory and antioxidant properties, as well as an antiviral effect on rotavirus. According to background information provided the investigators, some chronic hepatitis C patients who regularly use stevioside have exhibited decreased HCV RNA or undetectable viral load in the absence of interferon-based therapy.
In the present study, the researchers evaluated the antiviral effect of stevioside on HCV replication using HCV replicon systems. They used ORN/C-5B/KE cells supporting genome-length HCV RNA encoding the luciferase reporter gene, and O cells replicating the genome-length HCV RNA in a real-time transcription polymerase chain reaction analysis.
Both cell systems were exposed to several concentrations of sterilized stevioside. The investigators assessed cytotoxicity, effect on signal transduction pathways, and anti-HCV activity (with and without interferon).
Results
• A diluted solution of stevioside demonstrated no cytotoxicites to either ORN/C-5B/KE cells or O cells.
• In both replicon systems, diluted stevioside suppressed HCV RNA in a dose-dependent manner.
• A 1000 times diluted stevioside solution inhibited HCV replication by about 30%.
• The same solution activated interferon-stimulated response element and 2-5A synthesizing enzyme gene promoter, but not the NF-kappa-?B gene promoter.
• Exposure to stevioside and interferon in combination produced an additive, but not a synergistic antiviral effect.
"We showed [the] anti-HCV effect of stevioside and the additive anti-HCV effect by combination of stevioside with interferon in vitro, and the activation of interferon signal was considered as one of the mechanism[s]," the investigators stated.
Thus, they concluded that, "stevioside is a possible antiviral agent for hepatitis C virus infection," and they plan to conduct a pilot study of the safety and efficacy of stevioside therapy for patients with chronic hepatitis C.
Top
Curcumin
Looking at another herbal therapy, Anping Chen and colleagues presented 3 laboratory studies assessing at the effect of curcumin on hepatic stellate cells.
Curcumin is the main component of the curry spice turmeric, derived from the Curcuma longa plant. Prior research indicates that it has antioxidant, anti-inflammatory, and anti-tumor properties. Hepatic stellate cells produce extracellular matrix proteins such as collagen that are responsible for liver fibrosis.
In the first study, the investigators found that curcumin promotes peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene expression and suppresses expression of the low-density lipoprotein (LDL) cholesterol receptor gene, which in turn lowers the level of intracellular cholesterol and thereby reduces the stimulatory effect of LDL on hepatic stellate cell activation.
In the second study, the researchers demonstrated that curcumin diminished the activating effect of oxidized LDL on stellate cells by suppressing LOX-1 gene expression, again via PPAR-gamma activation. Conversely, pre-treating the cells with a PPAR-gamma antagonist (PD68235) eliminated the inhibitory effect of curcumin.
Finally, the investigators showed that by increasing oxidative stress, insulin stimulates hepatic stellate cell proliferation and collagen production. But curcumin suppressed insulin-induced stellate cell activation by interrupting the insulin signaling pathway and reducing oxidative stress, via the same PPAR-gamma mechanism.
Hyperlipidemia (elevated blood lipid levels), obesity, and insulin resistance are features of the metabolic syndrome, which is associated with liver steatosis (accumulation of fat in hepatocytes). Steatosis is linked to fibrosis in individuals with non-alcoholic fatty liver disease, as well as those with chronic hepatitis C. Further, steatosis and insulin resistance are factors associated with poor response to interferon-based anti-HCV therapy.
The results of these laboratory studies suggest that curcumin or related agents that work by a similar mechanism might reduce fibrosis associated with hyperlipidemia or insulin resistance in individuals with or without hepatitis C.
6/10/08
References
K Yuasa, K Sato, A Naganuma, and others. Stevioside as a possible antiviral agent for hepatitis C virus infection. Digestive Disease Week (DDW) 2008. San Diego, CA. May 17-22, 2008. Abstract S1943.
Q Kang and A Chen. Curcumin suppresses LDL receptor gene expression, leading to the inhibition of cholesterol/LDL-induced hepatic stellate cell activation. Digestive Disease Week (DDW) 2008. San Diego, CA. May 17-22, 2008. Abstract S1584.
LET'S NOT DISCUSS SWEETENERS PROS AND CONS ON THIS THREAD.
Marcia
Herbal Product Stevioside Inhibits HCV Replication and Curcumin Suppresses Fibrogenic Cell Activity in Laboratory Studies
Last updated:26June2008
Intro
Stevioside
Curcumin
By Liz Highleyman hivandhepatitis.com
Intro
Given the suboptimal response rate and difficult side effects associated with standard interferon-based therapy for chronic hepatitis C virus (HCV) infection, many patients have used various alternative and complementary therapies, and researchers have assessed several such agents in laboratory and clinical studies.
At the Digestive Disease Week 2008 conference last month in San Diego, researchers reported on 2 plant-derived therapies that may have the potential to inhibit HCV and improve liver fibrosis.
Top
Stevioside
In the first study, Kazuhisa Yuasa and colleagues assessed the in vitro anti-HCV activity of stevioside, an agent derived from the leaves of the Stevia rebaudiana plant that is used as a natural non-caloric sweetener.
Stevioside has been reported to have anti-inflammatory and antioxidant properties, as well as an antiviral effect on rotavirus. According to background information provided the investigators, some chronic hepatitis C patients who regularly use stevioside have exhibited decreased HCV RNA or undetectable viral load in the absence of interferon-based therapy.
In the present study, the researchers evaluated the antiviral effect of stevioside on HCV replication using HCV replicon systems. They used ORN/C-5B/KE cells supporting genome-length HCV RNA encoding the luciferase reporter gene, and O cells replicating the genome-length HCV RNA in a real-time transcription polymerase chain reaction analysis.
Both cell systems were exposed to several concentrations of sterilized stevioside. The investigators assessed cytotoxicity, effect on signal transduction pathways, and anti-HCV activity (with and without interferon).
Results
• A diluted solution of stevioside demonstrated no cytotoxicites to either ORN/C-5B/KE cells or O cells.
• In both replicon systems, diluted stevioside suppressed HCV RNA in a dose-dependent manner.
• A 1000 times diluted stevioside solution inhibited HCV replication by about 30%.
• The same solution activated interferon-stimulated response element and 2-5A synthesizing enzyme gene promoter, but not the NF-kappa-?B gene promoter.
• Exposure to stevioside and interferon in combination produced an additive, but not a synergistic antiviral effect.
"We showed [the] anti-HCV effect of stevioside and the additive anti-HCV effect by combination of stevioside with interferon in vitro, and the activation of interferon signal was considered as one of the mechanism[s]," the investigators stated.
Thus, they concluded that, "stevioside is a possible antiviral agent for hepatitis C virus infection," and they plan to conduct a pilot study of the safety and efficacy of stevioside therapy for patients with chronic hepatitis C.
Top
Curcumin
Looking at another herbal therapy, Anping Chen and colleagues presented 3 laboratory studies assessing at the effect of curcumin on hepatic stellate cells.
Curcumin is the main component of the curry spice turmeric, derived from the Curcuma longa plant. Prior research indicates that it has antioxidant, anti-inflammatory, and anti-tumor properties. Hepatic stellate cells produce extracellular matrix proteins such as collagen that are responsible for liver fibrosis.
In the first study, the investigators found that curcumin promotes peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene expression and suppresses expression of the low-density lipoprotein (LDL) cholesterol receptor gene, which in turn lowers the level of intracellular cholesterol and thereby reduces the stimulatory effect of LDL on hepatic stellate cell activation.
In the second study, the researchers demonstrated that curcumin diminished the activating effect of oxidized LDL on stellate cells by suppressing LOX-1 gene expression, again via PPAR-gamma activation. Conversely, pre-treating the cells with a PPAR-gamma antagonist (PD68235) eliminated the inhibitory effect of curcumin.
Finally, the investigators showed that by increasing oxidative stress, insulin stimulates hepatic stellate cell proliferation and collagen production. But curcumin suppressed insulin-induced stellate cell activation by interrupting the insulin signaling pathway and reducing oxidative stress, via the same PPAR-gamma mechanism.
Hyperlipidemia (elevated blood lipid levels), obesity, and insulin resistance are features of the metabolic syndrome, which is associated with liver steatosis (accumulation of fat in hepatocytes). Steatosis is linked to fibrosis in individuals with non-alcoholic fatty liver disease, as well as those with chronic hepatitis C. Further, steatosis and insulin resistance are factors associated with poor response to interferon-based anti-HCV therapy.
The results of these laboratory studies suggest that curcumin or related agents that work by a similar mechanism might reduce fibrosis associated with hyperlipidemia or insulin resistance in individuals with or without hepatitis C.
6/10/08
References
K Yuasa, K Sato, A Naganuma, and others. Stevioside as a possible antiviral agent for hepatitis C virus infection. Digestive Disease Week (DDW) 2008. San Diego, CA. May 17-22, 2008. Abstract S1943.
Q Kang and A Chen. Curcumin suppresses LDL receptor gene expression, leading to the inhibition of cholesterol/LDL-induced hepatic stellate cell activation. Digestive Disease Week (DDW) 2008. San Diego, CA. May 17-22, 2008. Abstract S1584.
Thanks for running across it and posting it.
It surely caused some interesting discussions on the original thread. I hope that on this thread we will be able to establish how it should be taken.
Marcia
It surely caused some interesting discussions on the original thread. I hope that on this thread we will be able to establish how it should be taken.
Marcia
When I first got diagnosed, the first thing I actually looked into was curcumin, as in Indonesia it is widely used for any liver illnesses.
As my doctor warned me not to take any herbal stuff, (he doesn't have the knowledge, so it is best for him to advise against anything he does not understand .... fair enough), I backed off.
In Indonesia they use the the more potent curcuma xanthorrhiza (javanese trumeric) which is very bitter. They slice the root, boil it for about 20 minutes and then drink the liquid.
Marcia
As my doctor warned me not to take any herbal stuff, (he doesn't have the knowledge, so it is best for him to advise against anything he does not understand .... fair enough), I backed off.
In Indonesia they use the the more potent curcuma xanthorrhiza (javanese trumeric) which is very bitter. They slice the root, boil it for about 20 minutes and then drink the liquid.
Marcia
Hey, I just ran across this report and do not really know anything else about these substances. Thought it might gererate some intrest and maybe some info. Sorry, jerry
I have the Stevia Leaf Liquid Concentrate (dark liquid made from whole stevia leaves in a base of purified water) It says to use 5 drops in beverages or in cooking as desired.
1 serving corresponds to 0.14 ml* *daily value not established.
I totally agree with the pre and post tx possibilities. Actually I am more cautious about how to use them on tx, due to drug herb interactions. But that should at least not be a concern with stevia.
I wonder how we can find out what the 'medicinal' dosage of stevia should be.
Marcia
1 serving corresponds to 0.14 ml* *daily value not established.
I totally agree with the pre and post tx possibilities. Actually I am more cautious about how to use them on tx, due to drug herb interactions. But that should at least not be a concern with stevia.
I wonder how we can find out what the 'medicinal' dosage of stevia should be.
Marcia
Thank you for the thanks, for reposting the post. :-)
The one we really need to thank is orleans and I hope he will chime in with more info on this, despite we ended up totally trashing his original thread.
Marcia
The one we really need to thank is orleans and I hope he will chime in with more info on this, despite we ended up totally trashing his original thread.
Marcia
Have an Answer?
You are reading content posted in the Hepatitis C Community
Learn about this treatable virus.
Getting tested for this viral infection.
3 key steps to getting on treatment.
4 steps to getting on therapy.
What you need to know about Hep C drugs.
How the drugs might affect you.
These tips may up your chances of a cure.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
